Has Iman Abou-Chakra, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,999 in general payments to Iman Abou-Chakra, MD across 42 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Iman Abou-Chakra, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Iman Abou-Chakra, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Iman Abou-Chakra, MD

Physical Medicine & Rehabilitation · Jackson, MINPI 1952373078

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 42 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations. Among physical medicine & rehabilitation clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,999in general payments, 2019–2025

Across 42 payments — averaging $71.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$405
Teva Pharmaceuticals USA, Inc.$372
Novo Nordisk$209
Boston Scientific$176
Johnson & Johnson$145
Medtronic$137
plus $2K from 17 others

What the payments were for

Food & beverage$2,999100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	7	$405
Teva Pharmaceuticals USA, Inc.	6	$372
Novo Nordisk	3	$209
Boston Scientific	2	$176
Johnson & Johnson(2 entities)	2	$145
Medtronic	1	$137
E.r. Squibb & Sons, L.L.C.	2	$126
Sunovion Pharmaceuticals Inc.	1	$125
Bayer	1	$120
Inari Medical, Inc.	1	$117
Gilead	1	$115
Corcept Therapeutics	1	$115
Boehringer Ingelheim	1	$113
Dexcom, Inc.	1	$110
Amarin Pharma, Inc.	1	$110
Vertex	1	$108
Alkermes, Inc.	1	$93
Si-bone, Inc.	1	$89
Axsome Therapeutics, Inc.	1	$66
Lifenet Health	1	$56
Pfizer	3	$33
Stryker	1	$32
Amgen	2	$27

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,999 in reported general payments places this provider in the 90th percentile of 469 physical medicine & rehabilitation providers in Michigan.

See all physical medicine & rehabilitation providers in Michigan →

Medicare billing

Part B allowed, 2024

$73,055

Medicare patients

268

Services billed

859

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gabapentin	176	$2,183
Duloxetine Hcl	46	$965
Pregabalin	28	$286
Cyclobenzaprine Hcl	19	$214
Methocarbamol	11	$35
Diazepam	20	$9

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Jackson

Edward DabrowskiRoseville$167K
Erika ErlandsonAnn Arbor$54K
Gianna Maria RodriguezAnn Arbor$41K
Mathew SaffarianEast Lansing$24K
Jason PeterTroy$20K
David WiersemaSaginaw$17K
Satyum ParikhWarren$11K
Reginald KapteynMuskegon$11K
Emily GladstoneGrand Rapids$10K
In YoonDearborn$10K

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →